Fibrinogen as a risk factor for coronary heart disease and mortality in middle-aged men and women - The Scottish Heart Health Study

被引:132
作者
Woodward, M
Lowe, GDO
Rumley, A
Tunstall-Pedoe, H
机构
[1] Univ Dundee, Cardiovasc Epidemiol Unit, Dundee, Scotland
[2] Univ Reading, Dept Appl Stat, Reading RG6 2AH, Berks, England
[3] Univ Glasgow, Glasgow Royal Infirm, Dept Med, Glasgow G31 2ER, Lanark, Scotland
关键词
fibrinogen; coronary heart disease; all-causes mortality;
D O I
10.1053/euhj.1997.0573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Fibrinogen was measured in 5095 men and 4860 men aged 40-59 in a random population sample from 25 districts of Scotland recruited during 1984-87: the Scottish Heart Health Study. Fibrinogen was then related to the chance of fatal and non-fatal coronary events and death from any cause during a subsequent follow-up period of around 8 years. Methods and results Fibrinogen was measured by the Clauss assay. The effect of fibrinogen on coronary heart disease and death was assessed through age-adjusted means and Cox proportional hazards regression models, accounting for age, cotinine (a measure of tobacco smoke inhalation) and 11 other major coronary risk factors. Fibrinogen was found to be an important risk factor for coronary heart disease in men and women, with and without pre-existing coronary heart disease. There appears to be a threshold effect, with those in the highest fifth of the distribution having a much increased risk. Estimated age-adjusted hazard ratios by sex and pre-existing coronary heart disease group for the highest to lowest fifth of fibrinogen range between 1.93 and 4.86. Fibrinogen is also important as a risk factor for coronary death and all-causes mortality, with a similar threshold effect. Comparing the two extreme fifths, the hazard ratios for coronary death are 3.01 and 3.42, and for all-cause mortality are 2.59 and 2.20, for men and women respectively. Adjustment for cotinine reduces the hazard ratios, but further adjustment for the other 11 risk factors has little effect for coronary heart disease events. After full adjustment there is a remaining significant (P<0.05) hazard ratio for coronary death and death from any cause and for a coronary heart disease event for those free of coronary heart disease at baseline, amongst men, comparing the highest to the lowest fifth. Conclusion Fibrinogen is a strong predictor of coronary heart disease, fatal or non-fatal, new or recurrent, and of death from an unspecified cause, for both men and women. Its effect is only partially attributable to other coronary risk factors, the most important of which is smoking.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 40 条
[1]  
ANDEROSN B, 1990, METHODOLOGICAL ERROR
[2]   beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction - The ECTIM study [J].
Behague, I ;
Poirier, O ;
Nicaud, V ;
Evans, A ;
Arveiler, D ;
Luc, G ;
Cambou, JP ;
Scarabin, PY ;
Bara, L ;
Green, F ;
Cambien, F .
CIRCULATION, 1996, 93 (03) :440-449
[3]   NUTRIENT INTAKES OF DIFFERENT SOCIAL-CLASS GROUPS - RESULTS FROM THE SCOTTISH-HEART-HEALTH-STUDY (SHHS) [J].
BOLTONSMITH, C ;
SMITH, WCS ;
WOODWARD, M ;
TUNSTALLPEDOE, H .
BRITISH JOURNAL OF NUTRITION, 1991, 65 (03) :321-335
[4]   A SHORT RATING SCALE AS A POTENTIAL MEASURE OF PATTERN A BEHAVIOR [J].
BORTNER, RW .
JOURNAL OF CHRONIC DISEASES, 1969, 22 (02) :87-&
[5]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[6]   LIPOPROTEIN LP(A) AS PREDICTOR OF MYOCARDIAL-INFARCTION IN COMPARISON TO FIBRINOGEN - LDL CHOLESTEROL AND OTHER RISK-FACTORS - RESULTS FROM THE PROSPECTIVE GOTTINGEN RISK INCIDENCE AND PREVALENCE STUDY (GRIPS) [J].
CREMER, P ;
NAGEL, D ;
LABROT, B ;
MANN, H ;
MUCHE, R ;
ELSTER, H ;
SEIDEL, D .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1994, 24 (07) :444-453
[7]   FIBRINOGEN AS A CARDIOVASCULAR RISK FACTOR - A METAANALYSIS AND REVIEW OF THE LITERATURE [J].
ERNST, E ;
RESCH, KL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) :956-963
[8]   FIBRINOGEN GENOTYPE AND RISK OF PERIPHERAL ATHEROSCLEROSIS [J].
FOWKES, FGR ;
CONNOR, JM ;
SMITH, FB ;
WOOD, J ;
DONNAN, PT ;
LOWE, GDO .
LANCET, 1992, 339 (8795) :693-696
[9]  
GAFFNEY PJ, 1992, THROMB HAEMOSTASIS, V68, P428
[10]   BLOOD-PRESSURE, CIGARETTE-SMOKING AND HEART-ATTACK IN THE WHO CO-OPERATIVE TRIAL OF CLOFIBRATE [J].
GREEN, KG ;
HEADY, A ;
OLIVER, MF .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1989, 18 (02) :355-360